CMS and FDA have run the "parallel review" program for several years, one example of which was the Exact Sciences Cologuard screening test, which received a draft NCD on the same day as its FDA approval. (The draft NCD was finalized in a couple months).
CMS and FDA have released policymaking that the program will be permanently available. For the 8-page Federal Register notice, here.